Education
About Us
Working with TipRanks
Follow Us
BNB Plus (BNBX)
NASDAQ:BNBX
BNBX Stock Chart & Stats
$1.48
--
Market closed
$1.48
--
Day’s Range― - ―
52-Week Range$0.79 - $141.91
Previous CloseN/A
VolumeN/A
Average Volume (3M)1.96M
Market Cap
$3.49M
Enterprise Value-$453.08K
Total Cash (Recent Filing)$1.67M
Total Debt (Recent Filing)$193.25K
Price to Earnings (P/E)―
Beta2.93
Next Earnings
May 07, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding4,365,541
10 Day Avg. Volume46,292
30 Day Avg. Volume1,955,224
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)0.87
Price to Sales (P/S)0.94
P/FCF Ratio-0.16
Enterprise Value/Market Cap-0.13
Enterprise Value/Revenue-0.17
Enterprise Value/Gross Profit-0.59
Enterprise Value/Ebitda0.03
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
BNB Plus News
BNBX FAQ
What was BNB Plus’s price range in the past 12 months?
BNB Plus lowest stock price was $0.79 and its highest was $141.91 in the past 12 months.
What is BNB Plus’s market cap?
BNB Plus’s market cap is $3.49M.
When is BNB Plus’s upcoming earnings report date?
BNB Plus’s upcoming earnings report date is May 07, 2026 which is in 81 days.
How were BNB Plus’s earnings last quarter?
Currently, no data Available
Is BNB Plus overvalued?
According to Wall Street analysts BNB Plus’s price is currently Overvalued.
Does BNB Plus pay dividends?
BNB Plus does not currently pay dividends.
What is BNB Plus’s EPS estimate?
BNB Plus’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does BNB Plus have?
BNB Plus has 4,365,541 shares outstanding.
What happened to BNB Plus’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of BNB Plus?
Currently, no hedge funds are holding shares in BNBX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
BNB Plus
BNB Plus Corp. is a biotechnology company, which engages in the development and commercialization of technologies to produce and detect deoxyribonucleic acid and ribonucleic acid. It operates through the following segments: Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. The Therapeutic DNA Production Services segment consists of the enzymatic manufacture of synthetic DNA for use in the production of nucleic acid-based therapeutics and the development and sale of a proprietary RNAP for use in the production of mRNA therapeutics. The MDx Testing Services segment develops clinical molecular diagnostic and genetic tests and clinical laboratory testing services. The DNA Tagging and Security Products and Services segment is involved in the detection of DNA for industrial supply chains and security services. The company was founded in 1983 and is headquartered in Stony Brook, NY.
Technical Analysis
ENDRA Life Sciences
―
Intelligent Bio Solutions
―
iSpecimen
―
BioNexus Gene Lab Corp
―
Mainz Biomed B.V.
―
Ownership Overview
3.35% Insiders
0.08% Mutual Funds
<0.01% Other Institutional Investors
96.57% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---